Modern Authentication of Pharmaceuticals Act of 2025

Sponsored byRep. Davis, Donald G. [D-NC-1]NC· Introduced 6 février 2025

Open on Congress.gov

Cosponsors

Actions

Amendments

Committees

—

Since introduced

Introduced

Committee

Passed Chamber

Passed Both

Enacted

Step 1 of 0

Latest action

Referred to the House Committee on Energy and Commerce.

6 février 2025·1 year ago

Summary

Introduced in House · Updated 6 juin 2025

Modern Authentication of Pharmaceuticals Act of 2025

This bill requires each dose of a pharmaceutical product that is a controlled substance and that is taken orally in solid form (i.e., pills) to include a physical chemical identifier. (Physical chemical identifiers are substances that possess a unique physical or chemical property, such as inks, pigments, flavors, and molecular taggants, that unequivocally identify and authenticate a drug or dosage.) Under the bill, physical chemical identifiers must be included in or on the product and must be machine readable.

The bill applies to products manufactured beginning five years after the bill's enactment.

Timeline

4 actions

Referred to the House Committee on Energy and Commerce.
6 février 2025 · IntroReferral
Sponsor introductory remarks on measure. (CR H519)
6 février 2025 · IntroReferral
Introduced in House
6 février 2025 · IntroReferral
Introduced in House
6 février 2025 · IntroReferral

Sponsorship

3 cosponsors

Sponsor

Rep. Davis, Donald G. [D-NC-1]NC

Cosponsors

Republican3100%

Republican:Rep. Fitzpatrick, Brian K. [R-PA-1]PA
Republican:Rep. Bacon, Don [R-NE-2]NE
Republican:Rep. Rutherford, John H. [R-FL-5]FL

Classification

Policy area

Health

Legislative subjects

Drug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesPrescription drugsSupply chain

Cosponsor momentum

Cumulative over time

Track Modern Authentication of Pharmaceuticals Act of 2025 as it moves through Congress